Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 05 May 2023

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases

in Cancer Immunity and Immunotherapy

Chunyu Wang
Shuai Mu
Xuhui Yang
Lingling Li
Haitao Tao
Fan Zhang
Ruixin Li
Yi Hu
Lijie Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1110949

1,882 views
3 citations

Original Research

Published on 03 May 2023

Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial

in Cancer Immunity and Immunotherapy

Cláudia S. Ferreira
Galina Babitzki
Irina Klaman
Oliver Krieter
Katharina Lechner
Johanna Bendell
Suzana Vega Harring
Florian Heil

Frontiers in Oncology

doi 10.3389/fonc.2023.1157596

6,105 views
6 citations

Original Research

Published on 03 May 2023

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Silje Beckinger
Tina Daunke
Leon Aldag
Sandra Krüger
Steffen Heckl
Daniela Wesch
Heiner Schäfer
Christoph Röcken
Sascha Rahn
Susanne Sebens

Frontiers in Oncology

doi 10.3389/fonc.2023.1160824

4,098 views
11 citations

Review

Published on 03 May 2023

The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment

in Cancer Immunity and Immunotherapy

Francesca Pontis
Luca Roz
Orazio Fortunato
Giulia Bertolini

Frontiers in Oncology

doi 10.3389/fonc.2023.1116783

4,535 views
9 citations

Original Research

Published on 02 May 2023

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials

in Cancer Immunity and Immunotherapy

Jeffrey R. Whiteaker
Lei Zhao
Regine M. Schoenherr
Dongqing Huang
Rachel A. Lundeen
Ulianna Voytovich
Jacob J. Kennedy
Richard G. Ivey
Chenwei Lin
Oscar D. Murillo

Frontiers in Oncology

doi 10.3389/fonc.2023.1168710

4,157 views
4 citations

Original Research

Published on 02 May 2023

Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Jian Shangguan
Xinyi Huang
Xu Liu
Zengfu Zhang
Xiaodong Zhang
Jinming Yu
Dawei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1195499

3,382 views
10 citations

Review

Published on 01 May 2023

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

in Cancer Immunity and Immunotherapy

Minhan Jiang
Steven Fiering
Qi Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1153066

4,499 views
9 citations

Mini Review

Published on 28 Apr 2023

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lingli Luo
Yuxin Liu
Jingfen Lu
Yifei Zhang
Gang Fan
Xiaojun Tang
Weiming Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1104888

3,318 views
4 citations

Review

Published on 28 Apr 2023

Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives

in Cancer Immunity and Immunotherapy

Shuang Zhang
Ying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1142081

14,175 views
26 citations

Case Report

Published on 28 Apr 2023

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

in Cancer Immunity and Immunotherapy

Jiabao Yang
Pengfei Xing
Yuehong Kong
Meiling Xu
Liyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1078915

4,248 views
8 citations

Review

Published on 27 Apr 2023

IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation

in Cancer Immunity and Immunotherapy

Alexander J. Muller
Arpita Mondal
Souvik Dey
George C. Prendergast

Frontiers in Oncology

doi 10.3389/fonc.2023.1165298

4,393 views
18 citations

Original Research

Published on 26 Apr 2023

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Xueyan Liang
Xiaoyu Chen
Huijuan Li
Yan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1113374

2,541 views
1 citation

Original Research

Published on 25 Apr 2023

A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma: a multicenter retrospective study

in Cancer Immunity and Immunotherapy

Qiuyue Wen
Xiaoqian Li
Kewei Zhao
Qiuhui Li
Fang Zhu
Gang Wu
Tongyu Lin
Liling Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1123469

2,253 views
4 citations

Review

Published on 24 Apr 2023

Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity

in Cancer Immunity and Immunotherapy

Ting Wang
Wangrui Peng
Meng Du
Zhiyi Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1167105

5,006 views
30 citations

Original Research

Published on 21 Apr 2023

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma

in Cancer Immunity and Immunotherapy

Xiaoyong Xiang
Peng Chen
Fengming Lan
Li Ma
Jing Jin
Ye Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1110281

2,264 views
5 citations

Original Research

Published on 20 Apr 2023

Concurrent sintilimab with sequential chemoradiotherapy for unresectable, stage III non-small cell lung cancer: a retrospective study

in Cancer Immunity and Immunotherapy

Shi Tang
Xiaofeng Cong
Dan Zheng
Chen Chen
Zengguang Liu
Jie Gao
Huimin Zhang
Youhao Zhang
Ziling Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1129989

2,497 views
5 citations